Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SKLB-23bb is an orally bioavailable HDAC6-selective inhibitor and also has microtubule-disrupting ability.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 107.00 | |
2 mg | In stock | $ 155.00 | |
5 mg | In stock | $ 313.00 | |
10 mg | In stock | $ 457.00 | |
25 mg | In stock | $ 753.00 | |
50 mg | In stock | $ 1,060.00 | |
100 mg | In stock | $ 1,430.00 |
Description | SKLB-23bb is an orally bioavailable HDAC6-selective inhibitor and also has microtubule-disrupting ability. |
Targets&IC50 | HDAC6:17 nM |
In vivo | In vivo efficacy evaluations of colorectal HCT116, acute myelocytic leukemia MV4-11, and B cell lymphoma Romas xenografts, SKLB-23bb more effectively inhibited the tumor growth than SAHA even at a 4-fold reduced dose or ACY-1215 at the same dose. SKLB-23bb is a potent oral anticancer candidate for selective HDAC6 inhibitor. |
Molecular Weight | 396.44 |
Formula | C21H24N4O4 |
CAS No. | 1815580-06-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 32 mg/mL (80.72 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SKLB-23bb 1815580-06-3 Chromatin/Epigenetic DNA Damage/DNA Repair HDAC SKLB 23bb Histone deacetylases Inhibitor inhibit SKLB23bb inhibitor